Connect with us

JAMMU & KASHMIR

Blood pressure medicines don’t increase risk of COVID: DAK | KNO

Published

on

kno news

Srinagar, June 01 (KNO): Doctors Association Kashmir (DAK) on Monday said blood pressure medicines do not increase the risk of infection, serious illness or death from the novel coronavirus. “It is perfectly safe to continue your blood pressure medication during the Covid pandemic,” said DAK President Dr Nisar-u-Hassan in a statement issued to news agency—Kashmir News Observer (KNO) “People have apprehensions that ACE inhibitors and ARBs, two classes of drugs that are widely prescribed for high blood pressure increase the risk of Covid infection and the likelihood of severe illness among those infected with the novel virus,” he said. “ACE inhibitors include enalapril, lisinopril, captopril and other drugs with generic names ending in –pril; ARBs include Losartan, telmisartan, olmesartan and other generic drugs ending in –sartan,” he added. Dr Nisar said speculations about worse outcomes among patients on these medications during the Covid pandemic have caused widespread anxiety among patients and their care providers. Quoting three studies published in New England Journal of Medicine, Dr Nisar said no link was found between the use of blood pressure drugs and coronavirus infection. “It was also revealed that patients on these drugs faced no increase in risk of becoming severely ill with Covid infection,” he added. Dr Nisar said the articles showed no association between use of the two classes of blood pressure drugs of concern and dying from COVID-19. “In fact, some studies suggest that these drugs might reduce lung injury in people infected with the novel virus,” he said. Dr Nisar said it is vitally important to keep your blood pressure well controlled and take medication as advised. “Having high blood pressure has been associated with higher rate of dying from Covid-19,” he said. “People should stick with their blood pressure medication because high blood pressure is a risk factor for heart attack, stroke and kidney failure,” said Dr Nisar –(KNO)

Trending

TOP STORIES ago

Meet the Iranian face of Zojila breakthrough | KNO

TOP STORIES ago

Kashmir parts witness hailstorms, heavy rainfall; heatwave persists across Jammu | KNO

TOP STORIES ago

Strict NDPS action, public participation key to combat drug menace: IGP Kashmir | KNO

TOP STORIES ago

J&K mandates mother tongue, home language as instruction medium in schools | KNO

TOP STORIES ago

Private hospitals to de-empanel from Ayushman Bharat-SEHAT from July 1 if pending dues not cleared | KNO

TOP STORIES ago

Special Katra-Haridwar train on June 14-15 for Somvati Amavasya rush | KNO

TOP STORIES ago

Admin ensuring foolproof Muharram arrangements: Dy CM | KNO

TOP STORIES ago

AIIMS Awantipora to transform Kashmir’s healthcare landscape: MoS defence Sanjay Seth | KNO

TOP STORIES ago

J&K sees 42% precipitation deficit during January-May | KNO

TOP STORIES ago

Gulmarg Gondola closure extended indefinitely | KNO

TOP STORIES ago

Bandipora celebrates as NHAI invites bids for Sumbal-Gurez highway DPR | KNO

TOP STORIES ago

PMAY 2.0 beneficiary list under scanner as Anantnag residents allege irregularities, demand probe | KNO

TOP STORIES1 hours ago

Zojila Tunnel will improve lives of people: CM Omar | KNO

TOP STORIES1 hours ago

Zojila Tunnel breakthrough ‘golden chapter' in India's infrastructure history: Nitin Gadkari | KNO

TOP STORIES1 hours ago

Zojila Tunnel will usher new-era of connectivity between J&K and Ladakh: LG Sinha | KNO

TOP STORIES1 hours ago

J&K Govt appoints Suresh Kumar Gupta as SWRRA chairperson | KNO

TOP STORIES1 hours ago

J&K small hydropower sector welcomes Centre’s new hydro & climate safety push | KNO

Copyright © 2021